Eargo Revenue and Competitors
Estimated Revenue & Valuation
- Eargo's estimated annual revenue is currently $85.5M per year.
- Eargo received $52.0M in venture funding in March 2019.
- Eargo's estimated revenue per employee is $348,980
- Eargo's total funding is $217.2M.
- Eargo's current valuation is $216.3M. (January 2022)
Employee Data
- Eargo has 245 Employees.
- Eargo grew their employee count by -21% last year.
Eargo's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | SVP & Chief Accounting Officer | Reveal Email/Phone |
4 | VP Advanced Development Systems and Hardware Engineering | Reveal Email/Phone |
5 | Head Product Management | Reveal Email/Phone |
6 | Associate General Counsel and Chief Compliance Officer | Reveal Email/Phone |
7 | Head Retail | Reveal Email/Phone |
8 | VP, Field Sales | Reveal Email/Phone |
9 | VP People Operations | Reveal Email/Phone |
10 | VP, Strategic Reimbursement and Access | Reveal Email/Phone |
Eargo Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.6M | 54 | -47% | $31M | N/A |
#2 | $185.9M | 655 | 22% | N/A | N/A |
#3 | $346.1M | 1379 | -1% | N/A | N/A |
#4 | $13.9M | 63 | 29% | $77.7M | N/A |
#5 | $2442.6M | 6972 | 1% | $430.2K | N/A |
#6 | $21.3M | 79 | 5% | N/A | N/A |
#7 | $192M | 569 | 7% | N/A | N/A |
#8 | $48.6M | 155 | 6% | $318.8M | N/A |
What Is Eargo?
We're Eargo. A company made up of ENT surgeons, tech geeks and dreamers, united in our belief that people should be able to hear life to the fullest. Because the world is full of great things to hear. And because, well, we really like people. It's because we like people that we do what we do. We want the best for them, and this is our way to make sure they get it (we also like pina coladas, cuddly puppies and long walks on the beach, in case you're wondering). We don't believe that caring for your hearing health should come at the cost of compromising your lifestyle or appearance. That's why we've created devices that work superbly, are easy to use and - because of our patented Flexi Fibers - are incredibly comfortable and essentially invisible. We start with the user, the person who's going to open the Eargo box with eager anticipation, and build all of our products and experiences in ways that make them feel understood and cared for. That pays off their eager anticipation. We feel that the best technology should be natural, not intrusive. That is should serve us, not the other way around. Through improving hearing, we want to help people live and feel better. Because, like we said before, we like people. Eargo is designed for mild to moderate hearing loss. Will not restore normal hearing. Full benefit best obtained with frequent use. Visit Eargo.com/guides for more information and labeling.
keywords:Healthcare,Medical Devices$217.2M
Total Funding
245
Number of Employees
$85.5M
Revenue (est)
-21%
Employee Growth %
$216.3M
Valuation
N/A
Accelerator
Eargo News
The brand includes these models: Eargo 6, Eargo 5, Eargo Neo Hifi, and Eargo Max. HearAssist Pro, The hearing aid has amplifiers that intensify...
Eargo Neo HiFI is also entirely in the canal type of hearing aid models and nearly invisible. Its batteries are rechargeable, making it one of...
Jan-2022: Eargo introduced Eargo 6, its sixth-generation FDA Class II exempt hearing aid and most powerful device. Eargo 6 features: Hearing...
San Jose, Calif.-based Eargo makes small, rechargeable hearing aids that sit in the user’s ear canal, so others can’t see them. They sell for between $1,850 or $3,000 for a pair, depending on the model. Users control settings, such as whether they’re in a crowded room or on a phone call, throug ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 245 | 18% | N/A |
#2 | $38.3M | 246 | 0% | $62M |
#3 | $42.3M | 246 | -21% | N/A |
#4 | N/A | 262 | 10% | N/A |
#5 | $37.9M | 265 | 29% | N/A |
Eargo Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2015-06-26 | $13.6M | A | Maveron | Article |
2015-12-10 | $25.0M | B | NEA | Article |
2017-10-20 | $45.0M | C | Nan Fung Life Sciences | Article |
2019-03-06 | $52.0M | D | Mulitple | Article |